Summary: For patients with type 2 diabetes (T2DM) and a systolic blood pressure less than 140 mmHg, avoiding additional antihypertensive treatment is associated with a lower risk of cardiovascular mortality compared to adding additional antihypertensive treatment to patients with T2DM and a SBP < 140 mmHg.

(Note: For patients with T2DM and a SBP > 140, this meta-analysis demonstrates benefits for all-cause mortality with treatment to further lower BP).

Strength of Recommendation = A